Emerging Bispecifics Myeloma Patients Should Know About | Dr. Joshua Richter | The Patient Story

We talked about what bispecifics in myeloma are in our previous video, and in this segment, myeloma specialist, Dr. Joshua Richter of Mt. Sinai, describes some of the emerging bispecifics he’s most excited about, including Regeneron 5458, talquetamab, and cevostamab.

In this Series: Our 6-part video series with Dr. Richter covers the latest updates following the biggest blood cancer/disease conference (ASH) held at the end of 2021 that looked forward to emerging and promising treatments in clinical trials in 2022 and beyond.

Featuring: Dr. Joshua Richter, Director of Multiple Myeloma at the Blavatnik Family-Chelsea Medical Center, Mount Sinai (NYC)

Full story & transcript → Updated Soon at www.ThePatientStory.com

Videos:
1) What Are Bispecifics in Multiple Myeloma? (For Patients and Caregivers): https://youtu.be/SGd-aJOczGE
2) Emerging Bispecifics Myeloma Patients Should Know About: https://youtu.be/2VO53d8VNBU
3) What to Expect with CAR T Cell Therapy and Bispecifics in Myeloma (2022): https://youtu.be/JM4RxjuMRuU
4) What are CELMoDs in Multiple Myeloma (& When Will They Be Available?): https://youtu.be/-4p1dDm7nWI
5) Questions to Ask My Doctor about New Myeloma Treatments: https://youtu.be/2TfVU5ObK78

The interview has only been edited for clarity.

Join Our Community:
Website : https://www.thepatientstory.com/
Facebook: @ThePatientStory
Instagram: @ThePatientStory
Twitter: @patient_story
______________________________
Contents of this video:

00:00 - Intro
00:16 - Updates on Regeneron 5458
04:17 - How long does it generally take the FDA to approve these drugs?
10:17 - How far off is talquetamab from a possible FDA approval?
11:13 - Describe the infusion schedule and dosages for bispecifics?
12:50 - Understanding how often patients get infusions for bispecifics (frequency)
15:19 - Update on cevostamab (FcRH5xCD3 bispecific)
18:16 - Can you sequence BCMA therapy?

____________________________

#ThePatientStory #multiplemyeloma #myeloma #clinicaltrials #relapsedrefractory #Patientcare #cancertreatment

Видео Emerging Bispecifics Myeloma Patients Should Know About | Dr. Joshua Richter | The Patient Story канала The Patient Story